SEC Form 5 · accession 0001214659-15-008505
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul F Truex
Officer — Chief Executive Officer
Period of report
Dec 31, 2015
Accepted (ET)
Dec 23, 2015 · 6:08 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2015 | A | 12,500 | $1.49 | A | 12,500 | D | |
| Common Stock | Jun 30, 2015 | J | 12,500 | $0.00 | D | 0 | D | |
| Common Stock | Jun 30, 2015 | J | 12,500 | $0.00 | A | 101,837 | I | By Trust |
| Common Stock | Jun 30, 2015 | G | 12,500 | $0.00 | D | 89,337 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 12,500 shares acquired under the Issuer's 2010 Employee Stock Purchase Plan on June 30, 2015.
- F2On June 30, 2015, the reporting person transferred 12,500 shares to the 2005 Truex Family Trust u/d/t April 20, 2005
- F3On June 30, 2015, the 2005 Truex Family Trust u/d/t April 20, 2005 gifted 12,500 shares to Indiana University.